Posts in tag

PBS


Latest PBS cuts just the beginning, Minister believes A “skyrocketing” number of medicines experiencing a reduction in their price in the April round of PBS cuts is only the beginning, …

Consumers, taxpayers and the national health system will benefit from the significant savings being delivered by medicine suppliers since 1 April, say Medicines Australia, the Generic and Biosimilar Medicines Association, …

Most pharmacies offering co-pay discount, Minister claims as first 6CPA trials are revealed More than three quarters of Australian pharmacies have offered the PBS co-pay discount, federal Minister for Health …

Be honest about the true cost of the $1 discount, Guild urges pharmacists Australian pharmacists must be honest about the impact of the $1 PBS co-pay discount on their chances …

The sustainability of the PBS has been highlighted by the release of Productivity Commission data which puts the cost of the PBS per person at a 10 year low, says …

The Government’s desire to control community pharmacy is starting to look dangerously Soviet, writes Peter Feros The Soviet era is long gone, but its spirit felt alive and well as …

The PBS delisting of Panadol Osteo needs to be reconsidered in the light of cost and clinical safety implications, says Painaustralia. The organisation has highlighted the risk of adverse clinical …

It is time the government ‘fessed up’ that Panadol Osteo has been de-listed from the PBS by mistake, says the Guild today. It says that in April last year PBAC set very clear criteria …

The co-payment of $1 discount is being offered by Discount Drug Stores (DDS), as it claims it will enable the group to offer better priced OTC meds and offset the PBS impact of …

Panadol Osteo could double in price due to regulatory changes, claims the Guild’s head. Speaking on national radio, David Quilty did not hold back on his feelings and explained his concerns, especially …

As 2016 looms, community pharmacies need to be prepared for the optional $1 script copayment discount, and the delisting of several medicines from the PBS, Guild executive director David Quilty …

A new report has found that investing in new medicines pays for itself by reducing other public health expenditure. The modeling, published in The impact of pharmaceutical innovation on premature …